Lorenzo Falchi, Anna Sureda, Sirpa Leppä, Joost S. P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, Sven de Vos, Harald Holte, Reid W. Merryman, Pieternella J. Lugtenburg, Pau Abrisqueta, Kim M. Linton, Gauri Sunkersett, Daniela Hoehn, Ali Rana, Aqeel Abbas, Jennifer Marek, Yi Hao, Andrew J. Steele, Christopher Morehouse, Martin Hutchings, David Belada. "Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma." Blood, 2025. doi:10.1182/blood.2025029909